Latest papers

Neonatal alloimmune thrombocytopenia.

Is it time to include screening for neonatal alloimmune thrombocytopenia in the general antenatal health care programme?

Fetal/neonatal allo-immune thrombocytopenia (FNAIT): past, present, and future.

Heterogeneity of HPA-3 alloantibodies: consequences for the diagnosis of alloimmune thrombocytopenic syndromes.

Immunologic and structural analysis of eight novel domain-deletion beta3 integrin peptides designed for detection of HPA-1 antibodies.

Neonatal alloimmune thrombocytopenia associated with maternal-fetal incompatibility for blood group B.

Three novel beta3 domain-deletion peptides for the sensitive and specific detection of HPA-4 and six low frequency beta3-HPA antibodies.

Fetal and neonatal alloimmune thrombocytopenia.

[Neonatal alloimmune thrombocytopenia in Croatia in 1997-2007].

Retinopathy of prematurity treatment and vitreous hemorrhage.

A systematic review and survey of the management of unexpected neonatal alloimmune thrombocytopenia.

Fetal and neonatal alloimmune thrombocytopenia: progress and ongoing debates.

[Foetal/neonatal alloimmune thrombocytopenia. A review and case report].

Advances and controversies in neonatal ICU platelet transfusion practice.

Do platelet transfusions in the NICU adversely affect survival? Analysis of 1600 thrombocytopenic neonates in a multihospital healthcare system.

Intrauterine fetal transfusions in the management of fetal anemia and fetal thrombocytopenia.

Management of alloimmune thrombocytopenia.

The importance of using multiple techniques for detection of platelet antibodies.

Severe fetomaternal alloimmune thrombocytopenia due to anti-human platelet antigen (HPA)-1a in a mother with a rare and silenced ITGB3*0101 (GPIIIa) allele.

Severe HPA-15b related neonatal alloimmune thrombocytopenia.